Obalon Therapeutics, Inc.

Reshape Lifesciences Inc.

Dexcom, Inc.

Andrew P Rasdal

Mark C Brister

Neil R Drake

Amy D L VandenBerg

Antonio C Llevares

Dubravka Markovic

Matthew S Lake

Josefina Nider

Nelson Quintana

Paul D Faucher

Kaushik Aroonkumar Patel

Peter C Simpson

James H Brauker

Paul V Neale

Daniel J Proctor

Sheldon Nelson

Betty Wong

Amy Dl VandenBerg

Keoni John Sundseth

Apurv Ullas Kamath

Paul V Goode, Jr

Paul Faucher

Dubravka Markvoic

Antonio C Lievares

Amy D L Vandenberg

Antonio Llevares

Amy DL Vandenberg

Amy D I Vandenberg

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, monitoring, and retrieving the same are provided.

Intragastric device

Intragastric volume-occupying devices and methods for treating obesity are provided. The devices, which are inflated by carbon dioxide, include an aluminum or silicon oxide barrier layer providing carbon dioxide retention and an alkylene vinyl alcohol polymer layer providing structural integrity in vivo.

Intragastric volume-occupying device and method for fabricating same

An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.

Devices and methods for treating obesity are provided. More particularly, intragastric devices and methods of fabricating, deploying, inflating, locating, tracking, monitoring, deflating, and retrieving the same are provided.

Systems and methods for determining failure of intragastric devices

A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.

Integrated receiver for continuous analyte sensor

Intragastric device system

Growing community of inventors

San Diego, CA, United States of America

Andrew P Rasdal